Irinotecan Liposome in Combination With Capecitabine

Clinical trial NCT06578052 · RECRUITING

Trial details

NCT number: NCT06578052
Sponsor: Junjie Hang
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2024-08-28
Primary completion: 2027-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.